• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

TMXLU:LX

25.1000 USD 0.00000.00%

As of 03:36:42 ET on 10/01/2014.

Snapshot for Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund (TMXLU)

Open: - High - Low: - Primary Exchange: Luxembourg
Volume: 0 52-Week Range: 18.0700 - 25.7700 Beta vs NBI: 0.9525

ETF Chart for TMXLU

No chart data available.
  • TMXLU:LX 25.1000
  • 1D
  • 1M
  • 1Y
25.1000
Interactive TMXLU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TMXLU

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equity securities of biotechnology companies and discovery research firms, located in the US and other countries (with market capitalisation of less than $2 billion).

Inception Date: Telephone: 352-46-66-67-1
Managers: EVAN MCCULLOCH
Web Site: www.franklintempleton.lu

Fundamentals for TMXLU

NAV -
Assets (M) (on 2014-08-31) 2,816.0540
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for TMXLU

No dividends reported

Performance for TMXLU

1-Month -2.30% 1-Year +24.57%
3-Month +9.13% 3-Year +39.90%
Year To Date +20.67% 5-Year +25.27%
Expense Ratio 2.71

Top Fund Holdings for TMXLU

Filing Date: 06/30/2014
Name Position Value % of Total
Gilead Sciences Inc 3,515,700 291,486,687 9.118%
Biogen Idec Inc 785,840 247,783,210 7.751%
Celgene Corp 2,767,200 237,647,136 7.434%
Amgen Inc 1,357,100 160,639,927 5.025%
Medivation Inc 1,994,000 153,697,520 4.808%
Regeneron Pharmaceuticals Inc 452,500 127,817,675 3.998%
Illumina Inc 592,400 105,767,096 3.309%
Incyte Corp 1,741,200 98,273,328 3.074%
Alexion Pharmaceuticals Inc 577,500 90,234,375 2.823%
Vertex Pharmaceuticals Inc 880,800 83,394,144 2.609%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil